MERCK & CO INC: FAVORABLE TREND IN OVERALL SURVIVAL WAS OBSERVED FOR KEYTRUDA MONOTHERAPY VERSUS PLATINUM DOUBLET CHEMOTHERAPY

Reuters · 1d ago

Please log in to view news